Biotech Currents

Biotech Currents

Share this post

Biotech Currents
Biotech Currents
ImmunoGen soars on ovarian cancer data: ~336% return from report price, ~153% blended return | $IMGN

ImmunoGen soars on ovarian cancer data: ~336…

Bill Langbein
May 8, 2023
1

Share this post

Biotech Currents
Biotech Currents
ImmunoGen soars on ovarian cancer data: ~336% return from report price, ~153% blended return | $IMGN

This thread is only visible to paid subscribers of Biotech Currents

Subscribe to view →

Comments on this post are for paid subscribers

Already a paid subscriber? Sign in
© 2025 Bill Langbein
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share